Stroke induced by splenectomy in hemoglobin Madrid: Autopsy clues to the underlying mechanism

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 2, 2005, Pages 141-144

  Kim, Byung Jo ^a,b   Park, Kun Woo ^a,d   Koh, Seong Beom ^a   Kim, Han Kyum ^a   Jung, Hye Lim ^c   Park, Min Kyu ^a   Lee, Dae Hie ^a  

^a Korea University College of Medicine   (South Korea)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Korea University Ansan Hospital   (South Korea)

Author keywords

Splenectomy; Stroke; Thrombotic angiopathy; Unstable hemoglobinopathy

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; AUTOPSY; BRAIN; BRAIN INFARCTION; CASE REPORT; CORONARY ARTERY; HEMOGLOBINOPATHY; HUMAN; HUMAN TISSUE; KIDNEY; LETHALITY; LIVER; LUNG; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SPAIN; SPLENECTOMY; STROKE; THROMBOEMBOLISM; VASCULAR DISEASE; VEIN THROMBOSIS;

EID: 15744391162     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000161568.59140.a3     Document Type: Article

References (14)

1. Kim JY, Park SS, Jung HL, Keum DH, Park H, Chang YH, et al. Hb Madrid [beta1 15(G17) Ala → Pro] in a Korean family with chronic hemolytic anemia. Hemoglobin 2000; 24:133-138.
2. Molchanova TP, Postnikov Yu V, Wilson JB, Webber BB, Gu LH, Sabio H, et al. Hb Madrid or alpha 2 beta (2)115(G17)Ala → Pro in a black teenager. Hemoglobin 1993; 17:251-254.
3. Dacie J. The unstable hemoglobin haemolytic anaemias. In: The haemolytic anaemias. Edinburgh: Churchill Livingstone; 1988, p. 322.
4. Boxer MA, Braun J, Ellman L. Thromboembolic risk of postsplenectomy thrombocytosis. Arch Surg 1978; 113:808-809.
5. Parker HH, Bynoe RP, Nottingham JM. Thrombosis of the portal venous system after splenectomy for trauma. J Trauma 2003; 54:193-196.
6. Gordon DH, Schaffner D, Bennett JM, Schwartz SI. Postsplenectomy thrombocytosis: its association with mesenteric, portal, and/or renal vein thrombosis in patients with myeloproliferative disorders. Arch Surg 1978; 113:713-715.
7. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000; 111:467-473.
8. Egan EL, Fairbanks VF. Postsplenectomy erythrocytosis in hemoglobin Koln disease. N Engl J Med 1973; 288:929-931.
9. Brodsky I, Kahn SB, Ross EM, Petkov G. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders. Cancer 1972; 30:1444-1450.
10. Thuret I, Bardakdjian J, Badens C, Wajcman H, Galacteros F, Vanuxem D, et al. Priapism following splenectomy in an unstable hemoglobin: hemoglobin Olmsted beta 141 (H19) Leu → Arg. Am J Hematol 1996; 51:133-136.
11. Rose C, Bauters F, Galacteros F. Hydroxyurea therapy in highly unstable hemoglobin carriers. Blood 1996; 88:2807-2808.
12. Loukopoulos D. New therapies for the hemoglobinopathies [recent advances in the treatment for the hemoglobinopathies]. J Intern Med 1997; 242(suppl. 740):43-48.
13. Nahavandi M, Wyche MQ, Perlin E, Tavakkoli F, Castro O. Nitric oxide metabolites in sickle cell anemia patients after oral administration of hydroxyurea; hemoglobinopathy. Hematology 2000; 5:335-339.
14. Chou R, DeLoughery TG. Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency. Am J Hematol 2001; 67:197-199.